Asymchem Laboratories Tianjin Starts API Workshop Operation
This article was originally published in PharmAsia News
Executive Summary
Asymchem Laboratories (Tianjin), China's leading pharmaceutical R&D outsourcing company, recently started operating its active pharmaceutical ingredient workshop in the Tianjin Economic-Technological Development Area. With two independent production lines (50L and 100L), the facility can process raw pharmaceutical materials to produce tablets and capsules with APIs. In addition, it is also capable of small-scale R&D and oral solution output. The latest move will expand the firm's capability in high-efficiency compound R&D and production. (Click here for more - Chinese Language)